Correlation Engine 2.0
Clear Search sequence regions

  • humans (1)
  • polymer (4)
  • sirolimus (3)
  • stent (8)
  • Sizes of these terms reflect their relevance to your search.

    Despite recent advances in drug-eluting stent (DES) technology, late adverse events remain concerns after percutaneous coronary intervention. The persistence of polymer material on DES has been suggested as a trigger for chronic inflammation. The Firehawk, a novel DES, has a unique design with recessed abluminal grooves, to which sirolimus and biodegradable polymer are applied. The Firehawk stent is designed to minimize polymer volume and antiproliferative drug concentration to reduce inflammation and hypersensitivity reactions. Several recent trials have reported the clinical outcomes of this device. This article provides a review of the current clinical evidence concerning the Firehawk stent.


    Yuichi Saito, Daniel Grubman, Ecaterina Cristea, Alexandra Lansky. The Firehawk Stent: A Review of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent. Cardiology in review. 2020 Jul/Aug;28(4):208-212

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32032131

    View Full Text